Discontinued — last reported Q4 '14
is_adi_business_exit_costs| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Medical-Surgical Solutions | — | $3.00M | $3.00M | $19.00M | $25.00M | $12.00M | $14.00M | $2.00M |
| International | $9.00M | $0.00 | -$1.00M | $1.00M | — | $0.00 | — | — |
| North American Pharmaceutical | — | — | — | — | — | — | $1.00M | $0.00 |
| Prescription Technology Solutions | $8.00M | $3.00M | $0.00 | $0.00 | — | $0.00 | $0.00 | — |
| U.S. Pharmaceutical | $3.00M | $0.00 | $0.00 | $0.00 | — | $1.00M | — | — |
| Total | — | — | — | — | — | — | — | — |
International, Oncology & Multispecialty, Prescription Technology Solutions, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.